Clinical Trial Update: Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of an allogeneic nanostructured artificial human cornea for severe trophic corneal ulcers refractory to conventional treatment; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sequelae of Previous Trophic Corneal Ulcers
• Trophic Corneal Ulcers

Drugs mentioned

• Allogeneic nanostructured artificial human cornea

Snippet

Sponsor: Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Conditions: Severe Trophic Corneal Ulcers Refractory to Conventional Treatment, Sequelae of Previous Trophic Corneal Ulcers | Phase 1, Phase 2 | Status: COMPLETED